Sick LeaveFCENCT06158464
The Effectiveness of a Functional Capacity Evaluation Among Persons on Sick Leave or Work Disability
A study testing Functional Capacity Evaluation in people with Sick Leave and Absenteeism, run by KU Leuven at 8 sites in Belgium.
Trial summary
The goal of this clinical trial is to evaluate Functional Capacity Evaluations in persons on sick leave or work disability. The main questions it aims to answer are: What is the impact of FCE on the person on sick leave/work disability (quantitative) What is the impact of FCE on the decision-making process by the… Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Sick Leave, Absenteeism, Return to Work
- What is being tested?
- Functional Capacity Evaluation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 8 sitesBelgium
- Study dates
- 14 Sep 2023to 31 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- persons on sick leave or work disability (according to Belgian law)
- The person on sick leave/work disability is affected by an illness/injury that is considered stabilized (no significant medical evolution of the disease, nor a medical procedure or acute treatment is expected).
- The illness/injury of the person on sick leave/work disability is not mainly a mental/psychiatric disorder.
- From the point of view of the medical advisor, there is a lack of consistent information on the person on sick leave/work disability's capacity to return-to-work.
- Inclusion takes place from the 6th month of incapacity for work.
- The person on sick leave/work disability is of working age (18-65).
Who cannot join
- In the case of an accident at workplace, the medical condition of the person on sick leave/work disability has not yet been declared consolidated, meaning that the condition does not progress significantly, either naturally or with treatment.
- The medical advisor of the mutual health insurance is expecting in the near future: 1) a spontaneous return to work (total or partial), 2) a registration as a job-seeker, or 3) an end of the recognition of the work disability.
- The person on sick leave/work disability is pregnant.
- The medical advisor of the mutual health insurance perceives the person on sick leave/work disability does not have sufficient work capacity.
Trial locations and contacts
8 sites in 1 country.
8 sites in 1 country
Belgium8 sites, 8 recruiting
- Recruiting
MC Hainaut
Anderlues
Anne-Françoise Botte, MD
- Recruiting
LM Plus Antwerpen
Antwerp
Lise Bertels, MD
- Recruiting
Helan/Medisch kabinet Genk
Genk
Nathalie van Breugel, MD
- Recruiting
CM Gent
Ghent
Katrien De Reu, MD
Sofie Vertriest
- Recruiting
CM Vlaams-Brabant
Leuven
Kathleen Janssens, MD
- Recruiting
MC Liège
Liège
Alain Lopez, MD
- Recruiting
CM Oostende
Ostend
Siska Vergauwe, MD
- Recruiting
Mutsoc Luxembourg
Saint-Hubert
Mihail Lupea, MD
About this study
Official title: The Effectiveness of a Functional Capacity Evaluation (FCE) on the Return-to-work Process in Belgium: a Randomized Controlled Trial
The goal of this clinical trial is to evaluate Functional Capacity Evaluations in persons on sick leave or work disability. The main questions it aims to answer are:
- What is the impact of FCE on the person on sick leave/work disability (quantitative)
- What is the impact of FCE on the decision-making process by the medical advisor? (qualitative)
- What is the usability, feasibility and quality of FCE for the medical advisor, occupational therapist, mediators of the regional services, and return-to-work coordinators? (qualitative)
Read more
This is a randomized controlled trial (RCT). Participants in the control group will receive care-as-usual by the medical advisor. Participants in the intervention group will receive an FCE on top of care-as-usual. This is performed by an occupational therapist in their region, and a report of the FCE is delivered to the medical advisor. Both groups are asked to complete questionnaires at baseline, and after 3,6, and 9 months.
Researchers will compare questionnaire results from participants in the control and intervention group, to see if their workability (primary outcome), steps to return to work, expectations to return to work, return to work beliefs, time until (partial) reintegration, self-efficacy in return to work, pain scale, and illness perception (secondary outcomes) are affected differently.
Read the detailed description
This research project on the use of Functional Capacity Evaluations (FCE) within the context of benefit insurance in Belgium falls under the joint control of the National Institute for Sickness and Disability Insurance (RIZIV), the Haute École de Leonard Vinci and KU Leuven . KU Leuven hereby acts as the study's principal, but together with RIZIV and Haute École determines the objectives of the study as joint controllers.
An FCE consists of the evaluation of functional capacities based on medical reporting, observations and/or a series of standardised tests performed by an occupational therapist. This evaluation can give socially insured persons and medical advisors of the mutualities more insight into the participation possibilities of the socially insured person in function of the previous or next job. To date, the advisory doctor does not yet have the opportunity to have these evaluations carried out in Belgium. The aim of this study is therefore to examine the impact of these FCEs with regard to people on incapacity for work who meet the following conditions:
- Belgian citizens on sick leave or work disability who meet the criteria determined by the article 100§1 and 100 §2 of the coordinated law of 14 July 1994, or by article 19 and/or 20 of the RD 20 July 1971.
- The person's medical situation is stabilised (no significant evolution due to illness, procedure, treatment)
- It is not a purely mental/psychiatric disorder
- From the point of view of the consulting physician, there is a lack of consistent information on the capacity to return to work
- Inclusion takes place from the 6th month of incapacity
- The person is of working age: 18-65 years
In this RCT, 10 consulting physicians, 30 occupational therapists, and 200 persons on incapacity will be recruited. Then, persons on sick leave/work disability are randomly divided into two groups: 1) Persons in the control group receive the usual counselling by the medical advisor. 2) Persons in the intervention group receive usual care and an FCE. In the latter group, the person on sick leave is matched by the researchers to an occupational therapist in his region, and is invited to a FCE. After the evaluation, the person reviews the results with the occupational therapist, and a report of the FCE is provided to the medical advisor. Finally, the person is contacted by the medical advisor if they wish to take certain actions as a result of the FCE report. To measure the impact of the FCE, the intervention and control groups thereby complete a questionnaire at four points in time: at baseline, after 3 months, after 6 months, and after 9 months. This questionnaire is composed of validated instruments, and in addition to background characteristics, it questions work ability, self-efficacy, expectations of returning to work, any (steps taken to) return to work, pain intensity, illness perception, and beliefs regarding returning to work.
As a second objective, the impact on the medical advisors' (and other parties') decision-making process will be investigated through qualitative interviews and focus groups. To this end, a process evaluation will be conducted. This includes an examination of the implementation of the study, the usability, feasibility and quality of FCEs and their reporting, and the underlying causal mechanisms of the intervention. Using interviews and focus groups with medical advisors the impact of the FCE on the decision-making process will be investigated. Using interviews with occupational therapists, return-to-work coordinators and mediators of the regional services the usability, feasibility and quality of the FCE will be investigated.
- Conditions
- Sick Leave, Absenteeism, Return to Work
- Being tested
- Functional Capacity Evaluation
- Keywords
- return-to-work, functional capacity evaluation, randomized controlled trial, workability, occupational therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Functional Capacity EvaluationOther
In a FCE, an occupational therapist will evaluate a patient's ability to perform work-related tasks, using a battery of tests. Depending on the circumstances, he/she will for instance test fatigue, ask the patient to kneel, lift objects, or assess concentration. This assessment lasts ± 4 hours and includes physical tests and tests related to the (previous or reference) profession of the client. This means that an explicit match is made between the functional capacities of the patient (what is he/she capable of) and the demands of a certain job (what is he/she expected to do). Following this assessment, the occupational therapist will explain the results of this assessment to the patient. The evaluation will therefore take place during one or two visits.
| Study group | Role | What they receive |
|---|---|---|
| Care-as-usual | No intervention | In standard care, persons on sick leave/work disability are invited by the medical advisor for a consultation. If the patient is allocated to the control group (or if the patient did not agree to participate in the study), the medical advisor takes decisions based on the information at his disposal, e.g. start a return-to-work trajectory, to temporarily prolong sickness absence and disability, or to confirm definitive work disability. If they agree to participate, they are asked to complete four questionnaires: at baseline, at 3 months, 6 months, and 9 months. |
| Care-as-usual supplemented by a Functional Capacity Evaluation | Experimental | In the intervention group, participants are referred to an occupational therapist to receive an FCE. Afterwards, the occupational therapist completes a standardized FCE-template, and conveys these recommendations to the medical advisor. This template includes a list of ICF categories important to the work context. The conclusion of the FCE includes: 1) The facilitators and barriers related to work-related physical, cognitive or psychological functioning, or related to environmental and/or psychosocial factors. 2) A recommendation on the current or last occupation or a reference occupation with or without adaptation and/or on reorientation, training, coaching.
Based on the FCE results, the medical advisor can adapt his advice and communicate to the person on sick leave/work disability to advise him/her, or refer the person on sick leave/work disability to other partners (such as VDAB, FOREM, Actiris, or the RTW-coordinator). Receives: Other: Functional Capacity Evaluation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Workability
The single-item first WAI (Work Ability Index) question is a self-report question in which the person rates his "current work ability compared with the lifetime best", with a score of 0 ("completely unable to work") up to 10 ("work ability at its lifetime best").
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Secondary outcomes (6)
Self-efficacy in the context of return-to-work
The self-efficacy return to work scale is a 10 item self-report questionnaire consisting of three subdomains of self-efficacy: (1) ability to cope with pain, (2) ability to obtain help from supervisor, and (3) ability to obtain help from co-workers. (Brouwer et al., 2009, 2010). There are five response options; for each item the person is asked to rate his/her confidence on a five-point scale (0 = not at all certain, 4 = completely certain). Subscores and an overall score (i.e., summative score) can be obtained, with higher scores indicating better return-to-work self-efficacy.
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Expectations to return-to-work
A single-item question "To what extent do you think you will return to work?" with the 4 response options: 1 (to a low degree); 2 (to a certain degree); 3 (to a high degree); 4 (do not know)
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Steps to return-to-work
The participants indicate which steps they have undertaken in their return-to-work, multiple answers are possible. Answers range from following training programmes, looking for jobs, undergoing work-oriented rehabilitation, to returning to work at a new or former employee.
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Pain scale
The Graded Chronic Pain Scale Revised (GCPS-R) is a 5-item self-report questionnaire assessing (1) current pain, (2) limitations in life or work abilities, (3) general pain, (4) enjoyment of life, (5) interference with general activity. For items 1 and 2, responses options are Never/Some days/Most days/Everyday, for items 3 responses options are the following: from 0 (No pain) to 10 (Pain as bad as you can imagine) while for items 4 and 5 responses options are the following : from 0 (does not interfere) to 10 (completely interferes).
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Illness perception
The Brief IPQ has nine items, it is designed to measure patients' cognitive and emotional representations of their illness including consequences (item 1), timeline (item 2), personal control (item 3), treatment control (item 4), identity (item 5), coherence (item 6), concern (item 7), emotional response (item 8), and causes (item 9) (Broadbent et al., 2006). All of the items except the causal question are rated using a 0-to 10 response scale. Increases in item scores represent linear increases in the dimension measured.
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Return-to-work beliefs
The RTW Beliefs questionnaire is composed of 12 items divided into four subscale of general direct measures: intention (i.e., "I expect to/want to/intend to …"), attitude (i.e., "RTW is for me: harmful-beneficial/ good-bad/pleasant-unpleasant/worthless-useful"), subjective norms (i.e., "It is expected of me that I should … /I feel under social pressure to … /People who are important to me want me to …" ) , and perceived behavioural control (i.e., "I'm confident that I could … / for me RTW is (easy-difficult).
Measured: measured at baseline, and 3, 6 and 9 months post baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Dec 2023
- Study start14 Sep 2023
- Primary completion31 Aug 2024 (estimated)
- Study completion31 Aug 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sick LeaveStudies of the same condition, open and under way.
- More trials run by KU LeuvenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A randomised controlled trial will be set up (RCT). For this purpose, 10 consulting physicians, 30 occupational therapists, and 200 persons on incapacity will be recruited. Then, persons on sick leave/work disability are randomly divided into two groups: 1) Persons in the control group receive care-as-usual without modifications. 2) Persons in the intervention group receive usual care and a functional capacity evaluation (FCE). Both groups are asked to complete questionnaires at baseline, and after 3,6, and 9 months. Primary outcome is the difference in workability at 6 months follow-up.
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- KU Leuven
- Sponsor type
- University, hospital or other
- Collaborators
- Haute École Léonard de Vinci, National Institute for Health and Disability Insurance, Belgium
- Responsible party
- Principal investigator, Lode Godderis, KU Leuven
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06158464
- Sponsor's protocol ID
- FCE-study
- Acronym
- FCE
- Status last verified
- Jan 2024
- First submitted
- 28 Nov 2023
- Last updated
- 29 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Apart from the researchers, the National Institute for Health and Disability Insurance (NIHDI) will have access to the pseudonymised questionnaire data, as specified in a GDPR-contract. Selected questionnaire data as well as the FCE-results will be available to the occupational therapists, the medical advisor, the return-to-work coordinator, and the mediator of the regional services.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of a Functional Capacity Evaluation (FCE) on the Return-to-work Process in Belgium: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06158464
- Acronym / sponsor ID
- FCE / FCE-study
- Conditions
- Sick Leave, Absenteeism, Return to Work
- Keywords
- return-to-work, functional capacity evaluation, randomized controlled trial, workability, occupational therapy
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- KU LeuvenUniversity, hospital or other
- Collaborators
- Haute École Léonard de Vinci, National Institute for Health and Disability Insurance, Belgium
- Study start
- 14 Sep 2023 (actual)
- Primary completion
- 31 Aug 2024 (estimated)
- Study completion
- 31 Aug 2024 (estimated)
- First posted
- 6 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to evaluate Functional Capacity Evaluations in persons on sick leave or work disability. The main questions it aims to answer are:
- What is the impact of FCE on the person on sick leave/work disability (quantitative)
- What is the impact of FCE on the decision-making process by the medical advisor? (qualitative)
- What is the usability, feasibility and quality of FCE for the medical advisor, occupational therapist, mediators of the regional services, and return-to-work coordinators? (qualitative)
This is a randomized controlled trial (RCT). Participants in the control group will receive care-as-usual by the medical advisor. Participants in the intervention group will receive an FCE on top of care-as-usual. This is performed by an occupational therapist in their region, and a report of the FCE is delivered to the medical advisor. Both groups are asked to complete questionnaires at baseline, and after 3,6, and 9 months.
Researchers will compare questionnaire results from participants in the control and intervention group, to see if their workability (primary outcome), steps to return to work, expectations to return to work, return to work beliefs, time until (partial) reintegration, self-efficacy in return to work, pain scale, and illness perception (secondary outcomes) are affected differently.
Detailed description
This research project on the use of Functional Capacity Evaluations (FCE) within the context of benefit insurance in Belgium falls under the joint control of the National Institute for Sickness and Disability Insurance (RIZIV), the Haute École de Leonard Vinci and KU Leuven . KU Leuven hereby acts as the study's principal, but together with RIZIV and Haute École determines the objectives of the study as joint controllers.
An FCE consists of the evaluation of functional capacities based on medical reporting, observations and/or a series of standardised tests performed by an occupational therapist. This evaluation can give socially insured persons and medical advisors of the mutualities more insight into the participation possibilities of the socially insured person in function of the previous or next job. To date, the advisory doctor does not yet have the opportunity to have these evaluations carried out in Belgium. The aim of this study is therefore to examine the impact of these FCEs with regard to people on incapacity for work who meet the following conditions:
- Belgian citizens on sick leave or work disability who meet the criteria determined by the article 100§1 and 100 §2 of the coordinated law of 14 July 1994, or by article 19 and/or 20 of the RD 20 July 1971.
- The person's medical situation is stabilised (no significant evolution due to illness, procedure, treatment)
- It is not a purely mental/psychiatric disorder
- From the point of view of the consulting physician, there is a lack of consistent information on the capacity to return to work
- Inclusion takes place from the 6th month of incapacity
- The person is of working age: 18-65 years
In this RCT, 10 consulting physicians, 30 occupational therapists, and 200 persons on incapacity will be recruited. Then, persons on sick leave/work disability are randomly divided into two groups: 1) Persons in the control group receive the usual counselling by the medical advisor. 2) Persons in the intervention group receive usual care and an FCE. In the latter group, the person on sick leave is matched by the researchers to an occupational therapist in his region, and is invited to a FCE. After the evaluation, the person reviews the results with the occupational therapist, and a report of the FCE is provided to the medical advisor. Finally, the person is contacted by the medical advisor if they wish to take certain actions as a result of the FCE report. To measure the impact of the FCE, the intervention and control groups thereby complete a questionnaire at four points in time: at baseline, after 3 months, after 6 months, and after 9 months. This questionnaire is composed of validated instruments, and in addition to background characteristics, it questions work ability, self-efficacy, expectations of returning to work, any (steps taken to) return to work, pain intensity, illness perception, and beliefs regarding returning to work.
As a second objective, the impact on the medical advisors' (and other parties') decision-making process will be investigated through qualitative interviews and focus groups. To this end, a process evaluation will be conducted. This includes an examination of the implementation of the study, the usability, feasibility and quality of FCEs and their reporting, and the underlying causal mechanisms of the intervention. Using interviews and focus groups with medical advisors the impact of the FCE on the decision-making process will be investigated. Using interviews with occupational therapists, return-to-work coordinators and mediators of the regional services the usability, feasibility and quality of the FCE will be investigated.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- A randomised controlled trial will be set up (RCT). For this purpose, 10 consulting physicians, 30 occupational therapists, and 200 persons on incapacity will be recruited. Then, persons on sick leave/work disability are randomly divided into two groups: 1) Persons in the control group receive care-as-usual without modifications. 2) Persons in the intervention group receive usual care and a functional capacity evaluation (FCE). Both groups are asked to complete questionnaires at baseline, and after 3,6, and 9 months. Primary outcome is the difference in workability at 6 months follow-up.
| Arm | Type | Receives |
|---|---|---|
| Care-as-usual | No intervention | –In standard care, persons on sick leave/work disability are invited by the medical advisor for a consultation. If the patient is allocated to the control group (or if the patient did not agree to participate in the study), the medical advisor takes decisions based on the information at his disposal, e.g. start a return-to-work trajectory, to temporarily prolong sickness absence and disability, or to confirm definitive work disability. If they agree to participate, they are asked to complete four questionnaires: at baseline, at 3 months, 6 months, and 9 months. |
| Care-as-usual supplemented by a Functional Capacity Evaluation | Experimental | Other: Functional Capacity EvaluationIn the intervention group, participants are referred to an occupational therapist to receive an FCE. Afterwards, the occupational therapist completes a standardized FCE-template, and conveys these recommendations to the medical advisor. This template includes a list of ICF categories important to the work context. The conclusion of the FCE includes: 1) The facilitators and barriers related to work-related physical, cognitive or psychological functioning, or related to environmental and/or psychosocial factors. 2) A recommendation on the current or last occupation or a reference occupation with or without adaptation and/or on reorientation, training, coaching. Based on the FCE results, the medical advisor can adapt his advice and communicate to the person on sick leave/work disability to advise him/her, or refer the person on sick leave/work disability to other partners (such as VDAB, FOREM, Actiris, or the RTW-coordinator). |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- persons on sick leave or work disability (according to Belgian law)
- The person on sick leave/work disability is affected by an illness/injury that is considered stabilized (no significant medical evolution of the disease, nor a medical procedure or acute treatment is expected).
- The illness/injury of the person on sick leave/work disability is not mainly a mental/psychiatric disorder.
- From the point of view of the medical advisor, there is a lack of consistent information on the person on sick leave/work disability's capacity to return-to-work.
- Inclusion takes place from the 6th month of incapacity for work.
Key exclusion criteria (4 listed)
- In the case of an accident at workplace, the medical condition of the person on sick leave/work disability has not yet been declared consolidated, meaning that the condition does not progress significantly, either naturally or with treatment.
- The medical advisor of the mutual health insurance is expecting in the near future: 1) a spontaneous return to work (total or partial), 2) a registration as a job-seeker, or 3) an end of the recognition of the work disability.
- The person on sick leave/work disability is pregnant.
- The medical advisor of the mutual health insurance perceives the person on sick leave/work disability does not have sufficient work capacity.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Functional Capacity EvaluationIn a FCE, an occupational therapist will evaluate a patient's ability to perform work-related tasks, using a battery of tests. Depending on the circumstances, he/she will for instance test fatigue, ask the patient to kneel, lift objects, or assess concentration. This assessment lasts ± 4 hours and includes physical tests and tests related to the (previous or reference) profession of the client. This means that an explicit match is made between the functional capacities of the patient (what is he/she capable of) and the demands of a certain job (what is he/she expected to do). Following this assessment, the occupational therapist will explain the results of this assessment to the patient. The evaluation will therefore take place during one or two visits. | Other | Care-as-usual supplemented by a Functional Capacity Evaluation |
Primary outcome
Workability
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
The single-item first WAI (Work Ability Index) question is a self-report question in which the person rates his "current work ability compared with the lifetime best", with a score of 0 ("completely unable to work") up to 10 ("work ability at its lifetime best").
6 secondary outcomes
Self-efficacy in the context of return-to-work
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
Expectations to return-to-work
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
Steps to return-to-work
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
Pain scale
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
Illness perception
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
Return-to-work beliefs
Time frame: measured at baseline, and 3, 6 and 9 months post baseline
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2024.
- Individual participant dataSharing planned: Yes. Apart from the researchers, the National Institute for Health and Disability Insurance (NIHDI) will have access to the pseudonymised questionnaire data, as specified in a GDPR-contract. Selected questionnaire data as well as the FCE-results will be available to the occupational therapists, the medical advisor, the return-to-work coordinator, and the mediator of the regional services.
Related trials for Sick Leave
Recruiting
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
Substance Use Disorder, Mental Illness
Not yet recruiting
SmaRTWork - a Decision Support System to Promote Return to Work Among People Sick-listed With Musculoskeletal Disorders
Sick Leave, Musculoskeletal
RecruitingObservational study
Back on Track: Evaluation of an Occupational Reintegration Protocol for Employees With Musculoskeletal Disorders
Musculoskeletal Disorders (MSDs)
Not yet recruitingObservational study
WB6Dim-LTSA: Can Workplace Well-Being Scores Predict Collective Absenteeism?
Absenteeism, Sick Leave
Active, not recruiting
Assessment of Activity Limitations, a Basis for Understanding the Need for Sickness Certificate and Rehabilitation
Sick Leave
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
8 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Functional Capacity Evaluation in people with Sick Leave and Absenteeism, run by KU Leuven at 8 sites in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Jonas S Steel, PhD (+3216373079, jonas.steel@kuleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Workability (time frame: measured at baseline, and 3, 6 and 9 months post baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2024.